新世界旗下Humansa與港怡醫院及卓正醫療合作拓大灣區業務網絡
新世界集團旗下醫療健康業務Humansa宣布,與港怡醫院及卓正醫療簽定合作協議,拓展粵港澳大灣區業務網絡,兩企將成為Humansa在粵港澳大灣區醫健服務網絡內的核心夥伴,提供個人化一站式專業醫療及身心健康服務。
Humansa行政總裁蘇嘉威表示,在Humansa全新的個人化醫健服務新生態的概念下,品牌將積極與行業夥伴合作,而是次與港怡醫院及卓正醫療的合作為擴展品牌在香港及內地發展的第一步。在未來五年,Humansa將會透過於粵港澳大灣區建立龐大的業務網絡,打造新世代的綜合醫療及身心健康體驗。
港怡醫院執行總裁曾慶廉提到,部分初期的項目包括與健康保健及管理和早期診斷服務相關的服務,由專業醫護團隊提供支援。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.